Macular Pigment and Visual Performance in Glaucoma Patients
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine cross-sectional relationships between macular
pigment optical density (MPOD) and visual performance in glaucoma. Additionally, the
investigators wish to determine the effect of lutein, zeaxanthin, and mesozeaxanthin
supplementation on MPOD and visual performance in glaucoma patients.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Duke University Felipe Medeiros, MD
Collaborators:
Heidelberg Engineering GmbH Industrial Orgánica S.A. de C.V. MacuHealth LP